This research was funded by IMU University, with a reference number of BDS I-01/2021(07), IMU University, Kuala Lumpur, Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
Vyas K, Rathod M, Patel MM. Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer.Nanomedicine. 2023;49:102662. [DOI] [PubMed]
Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: Current perspectives.SAGE Open Med. 2021;9:20503121211034366. [DOI] [PubMed] [PMC]
Yang S, Li Z, Pan M, Ma J, Pan Z, Zhang P, et al. Repurposing of Antidiarrheal Loperamide for Treating Melanoma by Inducing Cell Apoptosis and Cell Metastasis Suppression In vitro and In vivo.Curr Cancer Drug Targets. 2024;24:1015–30. [DOI] [PubMed]
He X, Zhu L, Li S, Chen Z, Zhao X. Loperamide, an antidiarrheal agent, induces apoptosis and DNA damage in leukemia cells.Oncol Lett. 2018;15:765–74. [DOI] [PubMed] [PMC]
Regan RC, Gogal RM Jr, Barber JP, Tuckfield RC, Howerth EW, Lawrence JA. Cytotoxic effects of loperamide hydrochloride on canine cancer cells.J Vet Med Sci. 2014;76:1563–8. [DOI] [PubMed] [PMC]
Wu J, Guo Q, Li J, Yuan H, Xiao C, Qiu J, et al. Loperamide induces protective autophagy and apoptosis through the ROS/JNK signaling pathway in bladder cancer.Biochem Pharmacol. 2023;218:115870. [DOI] [PubMed]
Gong XW, Xu YH, Chen XL, Wang YX. Loperamide, an antidiarrhea drug, has antitumor activity by inducing cell apoptosis.Pharmacol Res. 2012;65:372–8. [DOI] [PubMed]
Zhou Y, Sridhar R, Shan L, Sha W, Gu X, Sukumar S. Loperamide, an FDA-approved antidiarrhea drug, effectively reverses the resistance of multidrug resistant MCF-7/MDR1 human breast cancer cells to doxorubicin-induced cytotoxicity.Cancer Invest. 2012;30:119–25. [DOI] [PubMed] [PMC]
Tregubenko P, Zvonarev V. Impact of Opioid Use in Hematological Malignancies: Clinical, Immunological and Concomitant Aspects.J Hematol. 2020;9:41–54. [DOI] [PubMed] [PMC]
Friesen C, Bacher S, Hormann I, Roscher M, Miltner E. Cytotoxic effects of opioids on cancer cell lines.Int J Clin Pharmacol Ther. 2011;49:60–2. [PubMed]
Chougule M, Patel AR, Sachdeva P, Jackson T, Singh M. Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer.Lung Cancer. 2011;71:271–82. [DOI] [PubMed] [PMC]
Johny J, Sadiq A, Anamika, Sreedhar S, Fida A, Rishna A. Role of oral microbiome in oral cancer: A review.Arch Dent Res. 2022;12:1–4. [DOI]
Khan S, Sinha R, Routray S, Dixit A. Implications and future perspectives. In: Routray S, editor. Microbes and oral squamous cell carcinoma. Singapore: Springer; 2022. pp. 163–72. [DOI]
Lee W, Chen H, Yang S, Liang C, Peng C, Lin F, et al. Bacterial alterations in salivary microbiota and their association in oral cancer.Sci Rep. 2017;7:16540. [DOI] [PubMed] [PMC]
Asangba AE, Mugisha L, Rukundo J, Lewis RJ, Halajian A, Cortés-Ortiz L, et al. Large Comparative Analyses of Primate Body Site Microbiomes Indicate that the Oral Microbiome Is Unique among All Body Sites and Conserved among Nonhuman Primates.Microbiol Spectr. 2022;10:e0164321. [DOI] [PubMed] [PMC]
Zeng B, Tan J, Guo G, Li Z, Yang L, Lao X, et al. The oral cancer microbiome contains tumor space-specific and clinicopathology-specific bacteria.Front Cell Infect Microbiol. 2022;12:942328. [DOI] [PubMed] [PMC]
Powers A, Dickstein DR, Mogno I, Barlow J, Chen S, Teng M, et al. Characterization of oral cavity microbiome in patients with OCSCC.Int J Radiat Oncol Biol Phys. 2024;118:e74–5. [DOI]
de Bem Prunes B, Nunes JS, da Silva VP, Laureano NK, Gonçalves DR, Machado IS, et al. The role of tumor acidification in aggressiveness, cell dissemination and treatment resistance of oral squamous cell carcinoma.Life Sci. 2022;288:120163. [DOI] [PubMed]
Pérez-Sayáns M, Somoza-Martín JM, Barros-Angueira F, Diz PG, Rey JMG, García-García A. Multidrug resistance in oral squamous cell carcinoma: The role of vacuolar ATPases.Cancer Lett. 2010;295:135–43. [DOI] [PubMed]
Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, et al. Oral squamous cell carcinomas: state of the field and emerging directions.Int J Oral Sci. 2023;15:44. [DOI] [PubMed] [PMC]
